[Significance of pharmacoeconomics].
Beresniak
A
A
Corporate Pharmacoeconomics Department (AB), Serono International S.A., Genève. ariel.beresniak@serono.com
Bouvenot
G
G
D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003661:Decision Support Techniques; D017850:Economics, Pharmaceutical; D005602:France